Science policy weekly roundup: May 4, 2018 ?>

Science policy weekly roundup: May 4, 2018

Apply to the ASBMB ATP today

Apply today to the American Society for Biochemistry and Molecular Biology’s Advocacy Training Program. The ASBMB ATP will provide a one-of-a-kind, hands-on experience for ASBMB members interested in gaining valuable experience in science policy and advocacy. The six-month externship will train leaders to build and maintain hubs of regional science advocacy. Click here to learn more and to apply.


2018 Hill Day recap

ASBMB Science Policy Analyst André Porter recaps the events of 2018 ASBMB Hill Day. Society members, including undergraduates, graduate students, postdocs, and faculty, attended 85 meetings with staff from the offices of their congressional representatives in Washington, D.C., to talk about the importance of funding life science research. Members of the ASBMB Public Affairs Advisory Committee also met with directors and staff from the National Institutes of Health and the National Science Foundation to discuss specific policies affecting the life science community. Read more here.


NINDS to limit grants to labs receiving more than $1 million

The National Institute of Neurological Disorders and Stroke will make it more difficult for labs with more than $1 million in National Institutes of Health funding to receive NINDS grants. Robert Finkelstein, the NINDS extramural research director, says that the money saved will be used to help fund early-career investigators and those at risk of closing their labs due to lack of funds. Read more here.


White House may limit travel by Chinese scientists to U.S.

Amid concerns that Chinese scientists in the U.S. are acquiring intellectual property for the Chinese government, sources in the White House have suggested that President Donald Trump is considering limiting the ability of Chinese scientists to work in the U.S. and visit U.S. scientific institutions. Leaders of several scientific organizations, including the Association of American Medical Colleges and the American Association for the Advancement of Science, have expressing concern that such action would harm the U.S. scientific enterprise. Read more here.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.